Kiora Pharmaceuticals, Inc.
KPRX
$2.10
$0.2111.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.25% | 1.85% | 48.08% | -23.74% | -53.64% |
| Total Depreciation and Amortization | 21.27% | 60.71% | 12.64% | 22.54% | -20.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -465.34% | -2.45% | 367.31% | -114.66% | 415.30% |
| Change in Net Operating Assets | 104.20% | -122.69% | -144.25% | -36.23% | 290.90% |
| Cash from Operations | 66.53% | -40.65% | -20.06% | -344.80% | 124.65% |
| Capital Expenditure | 98.76% | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 724.38% | -73.94% | 510.65% | 122.79% | 90.93% |
| Cash from Investing | 764.29% | -75.15% | 453.72% | 125.14% | 90.95% |
| Total Debt Issued | 75.00% | -- | -- | -- | -- |
| Total Debt Repaid | -75.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -100.00% | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -89.97% | 1,202.97% | 113.38% | -221.19% | 790.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 263.39% | -12,774.65% | 98.85% | -96.72% | 96.20% |